Yanez Michelle
Insider CIK 1958023 · INTI Director · MIRA Chief Financial Officer · TELO Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INTI Inhibitor Therapeutics, In | A Award | 2026-05-04 | 2026-08-04 | 50,000 | — | $0 | 1,221,271 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award | 2026-05-04 | 2026-08-04 | 50,000 | — | $0 | 1,221,271 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award | 2025-04-01 | 2025-04-07 | 50,000 | — | $0 | 896,271 | SEC↗ |
| MIRA MIRA PHARMACEUTICALS, INC. | A Award deriv | 2024-12-09 | 2024-12-10 | 150,000 | — | $0 | 150,000 | SEC↗ |
| TELO Telomir Pharmaceuticals, I | A Award deriv | 2024-08-27 | 2024-09-04 | 200,000 | — | $0 | 200,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | A Award | 2024-04-01 | 2024-05-16 | 50,000 | — | $0 | 896,271 | SEC↗ |
| MIRA MIRA PHARMACEUTICALS, INC. | A Award deriv | 2024-03-26 | 2024-03-27 | 150,000 | — | $0 | 57,799 | SEC↗ |
| MIRA MIRA PHARMACEUTICALS, INC. | A Award deriv | 2023-08-17 | 2023-08-21 | 20,000 | — | $0 | 20,000 | SEC↗ |
| INTI Inhibitor Therapeutics, In | J Other | 2023-05-05 | 2023-05-17 | 796,271 | — | $0 | 800,673 | SEC↗ |